Stock Events

Stock Events

Botanix Pharmaceuticals Limited 

$0.018000
44
+$0.00+7.14% Thursday 18:50

Statistics

Day High
0.02
Day Low
0.02
52W High
0.1341
52W Low
0.01
Volume
100,000
Avg. Volume
11,400
Mkt Cap
49.22M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Oct 996
$60.77
Apr 996
$60.77
Oct 995
$52.09
Apr 995
$52.09
Oct 994
$43.05
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

26AugExpected
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.03
-0.02
-0.01
0
Expected EPS
-0.009631738694586767
Actual EPS
-0.009631738694586767

Financials

-206.5%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
22.97MRevenue
-47.44MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BXPHF. It's not an investment recommendation.
BHP Group Limited
10
BHP.AU
Commonwealth Bank of Australia
8
CBA.AU
BetaShares NASDAQ 100
8
NDQ.AU
Apple
7
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap211.01M
Corbus Pharmaceuticals works on developing and commercializing novel therapeutics to treat inflammatory and fibrotic diseases, overlapping with Botanix's dermatological focus.
Aurora Cannabis
ACB
Mkt Cap253.87M
Aurora Cannabis is a major player in the cannabis industry, indirectly competing by exploring the medical applications of cannabis, including skin conditions.
Tilray Brands
TLRY
Mkt Cap631.5M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, potentially competing in the medical cannabis space.
Organigram Global
OGI
Mkt Cap171.32M
OrganiGram Holdings is a producer of medical cannabis, potentially competing in the same space as Botanix by targeting similar medical conditions.
CV Sciences
CVSI
Mkt Cap4.08M
CV Sciences operates in the hemp-derived CBD market, indirectly competing with Botanix by offering alternative treatments for similar conditions.

About

Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in West Perth, Australia.
Show more...
CEO
Howie McKibbon
Employees
11
Country
Australia
ISIN
AU000000BOT2

Listings

OTC Link
US
BXPHF
AU
AU
BOT.AU

0 Comments

Share your thoughts

FAQ

What is Botanix Pharmaceuticals Limited stock price today?▼
The current price of BXPHF is $0.02 USD — it has increased by +7.14% in the past 24 hours. Watch Botanix Pharmaceuticals Limited stock price performance more closely on the chart.
What is Botanix Pharmaceuticals Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Botanix Pharmaceuticals Limited stocks are traded under the ticker BXPHF.
Is Botanix Pharmaceuticals Limited stock price growing?▼
BXPHF stock has risen by +7.14% compared to the previous week, the month change is a +20% rise, over the last year Botanix Pharmaceuticals Limited has showed a -82% decrease.
What is Botanix Pharmaceuticals Limited market cap?▼
Today Botanix Pharmaceuticals Limited has the market capitalization of 49.22M
When is the next Botanix Pharmaceuticals Limited earnings date?▼
Botanix Pharmaceuticals Limited is going to release the next earnings report on March 03, 2027.
What were Botanix Pharmaceuticals Limited earnings last quarter?▼
BXPHF earnings for the last quarter are -0.01 USD per share, whereas the estimation was -0.01 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Botanix Pharmaceuticals Limited revenue for the last year?▼
Botanix Pharmaceuticals Limited revenue for the last year amounts to 22.97M USD.
What is Botanix Pharmaceuticals Limited net income for the last year?▼
BXPHF net income for the last year is -47.44M USD.
Does Botanix Pharmaceuticals Limited pay dividends?▼
Yes, BXPHF dividends are paid annual. The last dividend per share was 60.77 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Botanix Pharmaceuticals Limited have?▼
As of September 06, 2026, the company has 11 employees.
In which sector is Botanix Pharmaceuticals Limited located?▼
Botanix Pharmaceuticals Limited operates in the Health & Wellness sector.
When did Botanix Pharmaceuticals Limited complete a stock split?▼
The last stock split for Botanix Pharmaceuticals Limited was on June 16, 2016 with a ratio of 1000:3333.
Where is Botanix Pharmaceuticals Limited headquartered?▼
Botanix Pharmaceuticals Limited is headquartered in West Perth, Australia.